LU82844A1 - Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant - Google Patents

Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant Download PDF

Info

Publication number
LU82844A1
LU82844A1 LU82844A LU82844A LU82844A1 LU 82844 A1 LU82844 A1 LU 82844A1 LU 82844 A LU82844 A LU 82844A LU 82844 A LU82844 A LU 82844A LU 82844 A1 LU82844 A1 LU 82844A1
Authority
LU
Luxembourg
Prior art keywords
oil
pyridine
mmol
solution
reaction mixture
Prior art date
Application number
LU82844A
Other languages
English (en)
French (fr)
Inventor
J Lombardino
C Harbert
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU82844A1 publication Critical patent/LU82844A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01D—HARVESTING; MOWING
    • A01D34/00—Mowers; Mowing apparatus of harvesters
    • A01D34/001—Accessories not otherwise provided for
    • A01D34/003—Means for cleaning the machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C33/00—Moulds or cores; Details thereof or accessories therefor
    • B29C33/56—Coatings, e.g. enameled or galvanised; Releasing, lubricating or separating agents
    • B29C33/60—Releasing, lubricating or separating agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C70/00—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts
    • B29C70/68—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks
    • B29C70/84—Shaping composites, i.e. plastics material comprising reinforcements, fillers or preformed parts, e.g. inserts by incorporating or moulding on preformed parts, e.g. inserts or layers, e.g. foam blocks by moulding material on preformed parts to be joined
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/0604—Construction of the male part
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16C—SHAFTS; FLEXIBLE SHAFTS; ELEMENTS OR CRANKSHAFT MECHANISMS; ROTARY BODIES OTHER THAN GEARING ELEMENTS; BEARINGS
    • F16C11/00—Pivots; Pivotal connections
    • F16C11/04—Pivotal connections
    • F16C11/06—Ball-joints; Other joints having more than one degree of angular freedom, i.e. universal joints
    • F16C11/068—Special features relating to lubrication

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Composite Materials (AREA)
  • Environmental Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
LU82844A 1979-10-15 1980-10-13 Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant LU82844A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/085,011 US4246263A (en) 1979-10-15 1979-10-15 Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions
US8501179 1979-10-15

Publications (1)

Publication Number Publication Date
LU82844A1 true LU82844A1 (fr) 1981-06-04

Family

ID=22188737

Family Applications (1)

Application Number Title Priority Date Filing Date
LU82844A LU82844A1 (fr) 1979-10-15 1980-10-13 Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant

Country Status (39)

Country Link
US (1) US4246263A (sv)
JP (1) JPS5663962A (sv)
KR (2) KR840001614B1 (sv)
AR (3) AR226864A1 (sv)
AT (2) AT377513B (sv)
AU (1) AU517763B2 (sv)
BE (1) BE885709A (sv)
CA (1) CA1156231A (sv)
CH (1) CH646425A5 (sv)
CS (2) CS226020B2 (sv)
DD (2) DD154816B3 (sv)
DE (1) DE3038593A1 (sv)
DK (1) DK152427C (sv)
EG (1) EG14676A (sv)
ES (2) ES8201972A1 (sv)
FI (1) FI75560C (sv)
FR (1) FR2467199A1 (sv)
GB (2) GB2092133B (sv)
GR (1) GR70311B (sv)
HK (2) HK1185A (sv)
HU (2) HU183233B (sv)
IE (1) IE50665B1 (sv)
IL (1) IL61261A (sv)
IN (2) IN154554B (sv)
IT (1) IT1195269B (sv)
KE (2) KE3461A (sv)
LU (1) LU82844A1 (sv)
MY (2) MY8500325A (sv)
NL (1) NL8005652A (sv)
NO (1) NO156566C (sv)
NZ (1) NZ195246A (sv)
PH (1) PH18277A (sv)
PL (2) PL125314B1 (sv)
PT (1) PT71917B (sv)
SE (1) SE437023B (sv)
SG (2) SG56384G (sv)
SU (2) SU1083907A3 (sv)
YU (2) YU41740B (sv)
ZA (1) ZA806306B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371696A (en) * 1980-07-14 1983-02-01 Pfizer Inc. Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof
GB8405896D0 (en) * 1984-03-07 1984-04-11 Sandoz Ltd Organic compounds
EP0311616B1 (en) * 1986-06-17 1991-09-25 Biogen, Inc. Combinations of gamma interferons and anti-inflammatory or anti-pyretic agents for treating diseases
US6878743B2 (en) * 2001-09-18 2005-04-12 Sunesis Pharmaceuticals, Inc. Small molecule inhibitors of caspases
CA2599169C (en) * 2005-02-25 2013-10-22 Temple University - Of The Commonwealth System Of Higher Education Synthesis of (e)-alpha, beta unsaturated sulfides, sulfones, sulfoxides and sulfonamides
TW200917961A (en) * 2007-08-23 2009-05-01 Sumitomo Chemical Co Fluorine-containing organosulfur compound and pesticidal composition thereof
CN108530606B (zh) * 2018-04-19 2020-11-20 山东师范大学 一种pH敏感性医用聚氨酯脲材料及其制备方法
US11981625B2 (en) 2018-10-08 2024-05-14 Ecolab Usa Inc. Sulfide-based compounds and uses thereof
CN110483740B (zh) * 2019-08-12 2021-08-27 山东师范大学 一种聚合物、pH敏感性纳米囊泡及制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3409626A (en) * 1963-09-17 1968-11-05 Neisler Lab Inc Indolylethyl pyridinium quaternary ammonium compounds
NL144484B (nl) * 1967-07-26 1975-01-15 Merck & Co Inc Werkwijze ter bereiding van een geneesmiddel met anti-anflammatoire werking, alsmede werkwijze ter bereiding van de anti-inflammatoir werkzame aralkylmercaptoaminozuren.
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
US3636074A (en) * 1968-08-05 1972-01-18 Hooker Chemical Corp Novel mercaptophenol derivatives
US3591584A (en) 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
US3818009A (en) * 1969-12-29 1974-06-18 Lilly Co Eli Alpha, alpha-disubstituted-5-pyrimidinemethanes
US3676463A (en) 1970-10-15 1972-07-11 Pfizer Oxobenzofuran carboxamides
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
JPS52125170A (en) * 1976-04-12 1977-10-20 Yoshitomi Pharmaceut Ind Ltd Pyridine derivatives

Also Published As

Publication number Publication date
FI75560C (sv) 1988-07-11
YU262680A (en) 1983-09-30
MY8500325A (en) 1985-12-31
ZA806306B (en) 1981-10-28
FR2467199B1 (sv) 1984-12-28
PL125402B1 (en) 1983-05-31
PL125314B1 (en) 1983-04-30
BE885709A (fr) 1981-04-14
DD154816B3 (de) 1987-05-13
DE3038593A1 (de) 1981-04-23
KR830004263A (ko) 1983-07-09
DD154816A5 (de) 1982-04-21
GB2061928A (en) 1981-05-20
HU191824B (en) 1987-04-28
YU266882A (en) 1983-09-30
PT71917A (en) 1980-12-01
CH646425A5 (fr) 1984-11-30
NO803073L (no) 1981-04-21
GB2092133A (en) 1982-08-11
JPS6129342B2 (sv) 1986-07-05
IT1195269B (it) 1988-10-12
YU42059B (en) 1988-04-30
IE50665B1 (en) 1986-06-11
PL231782A1 (sv) 1982-03-01
DK403080A (da) 1981-04-16
NL8005652A (nl) 1981-04-21
KR840001614B1 (ko) 1984-10-11
DK152427B (da) 1988-02-29
EG14676A (en) 1985-03-31
ES495932A0 (es) 1982-01-16
CA1156231A (en) 1983-11-01
YU41740B (en) 1987-12-31
SG69184G (en) 1985-03-15
AU6324080A (en) 1981-04-30
KE3466A (en) 1984-11-09
GR70311B (sv) 1982-09-08
PT71917B (en) 1983-01-10
ATA268783A (de) 1985-07-15
SG56384G (en) 1985-03-08
SU1083907A3 (ru) 1984-03-30
SU1144617A3 (ru) 1985-03-07
IT8025324A0 (it) 1980-10-14
HK1185A (en) 1985-01-11
FR2467199A1 (fr) 1981-04-17
DK152427C (da) 1988-07-25
DE3038593C2 (sv) 1988-11-10
AR227089A1 (es) 1982-09-15
CS226020B2 (en) 1984-03-19
HK66887A (en) 1987-09-25
HU183233B (en) 1984-04-28
ES8206478A1 (es) 1982-08-16
ATA508980A (de) 1984-08-15
NO156566C (no) 1987-10-14
FI75560B (fi) 1988-03-31
JPS5663962A (en) 1981-05-30
ES8201972A1 (es) 1982-01-16
NZ195246A (en) 1983-07-15
IN163553B (sv) 1988-10-08
SE437023B (sv) 1985-02-04
FI803239L (fi) 1981-04-16
US4246263A (en) 1981-01-20
GB2061928B (en) 1983-06-02
AT377513B (de) 1985-03-25
SE8007193L (sv) 1981-04-16
IN154554B (sv) 1984-11-10
IL61261A0 (en) 1980-12-31
KR840001615B1 (ko) 1984-10-11
NO156566B (no) 1987-07-06
PH18277A (en) 1985-05-17
IE802125L (en) 1981-04-15
MY8500323A (en) 1985-12-31
AT379801B (de) 1986-03-10
AR226864A1 (es) 1982-08-31
ES505544A0 (es) 1982-08-16
CS226034B2 (en) 1984-03-19
PL227307A1 (sv) 1981-11-13
AR227576A1 (es) 1982-11-15
AU517763B2 (en) 1981-08-27
KE3461A (en) 1984-10-12
IL61261A (en) 1984-08-31
DD202543A5 (de) 1983-09-21
GB2092133B (en) 1983-03-16

Similar Documents

Publication Publication Date Title
EP0202164B1 (fr) Dérivés de (benzoyl-4 pipéridino)-2 phenyl-1 alcanols, leur préparation et leur application en thérapeutique
EP0109317A2 (fr) Dérivés de phényl-1 pipéridino-2 propanol, leur préparation, et médicaments qui les contiennent
EP0350403B1 (fr) Dérivés de (aza)naphtalènesultame, leurs procédés de préparation et les médicaments les contenant
EP0042781B1 (fr) Nouveaux dérivés de (quinolyl-4)-1 (pipéridyl ou pyrrolidinyl-2 ou -3)-2 ou -3 éthanone ou propanone, procédés pour leur préparation, et leur utilisation comme médicaments
EP0001534B1 (fr) Nouveaux dérivés du pyrrole, leur procédé de préparation et leurs applications en thérapeutique
EP0468884B1 (fr) Nouveaux dérivés de benzimidazole, leur préparation, et leur application en tant que médicaments
LU82844A1 (fr) Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant
EP0388309A2 (fr) Nouveaux dérivés du 1h,3h-pyrrolo [1,2-c] thiazolecarboxamide-7, leur préparation et les compositions pharmaceutiques qui les contiennent.
EP0418933A1 (fr) Dérivés d'alcadiènes, leurs préparations, les médicaments les contenant et produits intermédiaires
EP0366511A1 (fr) Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
EP0410834A1 (fr) Médicaments à base de dérivés de benzoxadiazine-4, 1, 2 nouveaux dérivés et leurs procédés de préparation
CH641798A5 (fr) Derives de dibenzothiepinne et leur procede de synthese.
KR900006724B1 (ko) 벤조티아진 디옥사이드 유도체
EP0006789A1 (fr) Composés bis (aryloxyalcanecarboxyliques), leur préparation et leur utilisation en thérapeutique
US4535084A (en) Certain 4-(2-hydroxyethylthiomethyl)pyridines and derivatives thereof having immunoregulatory activity
CA2022732A1 (fr) Derives d'oxazolo pyridines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2509725A1 (fr) (hydroxyalkyl)phenylsulfures, leurs procedes de preparation et compositions pharmaceutiques les contenant
JPS5849369A (ja) 新規のイミダゾール化合物
EP0074873A1 (fr) Dérivés de phénoxy-3 propanol-2, leur préparation et leur application en thérapeutique
EP0294258A1 (fr) Dérivés d'hydrazine, procédé d'obtention et compositions pharmaceutiques les contenant
CH648483A5 (fr) Composition pharmaceutique contre l'arthrite rhumatoide.
EP0002635A1 (fr) Procédé de préparation de dérivés de thiéno (2,3-c) et (3,2-c) pyridines, nouveaux dérivés de la thiéno (2,3-c) pyridine obtenus et leur application thérapeutique
EP0412898A1 (fr) Nouveaux dérivés d'oxazolo pyridines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0078765A1 (fr) Dérivés de p-acylaminophénol à effet thérapeutique, procédé pour leur préparation, et composition à effet thérapeutique contenant lesdits dérivés à titre d'ingrédients pharmacologiquement actifs
FR2475543A1 (fr) Derives benzylideniques, leur preparation et leur application en therapeutique